Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06013137 · ClinicalTrials.gov registry record · NA

Chatbot for Depression, Anxiety, and Eating Disorders

A NA study of Depression and Anxiety, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
210
Enrollment target
1
Study location

NCT06013137 is a NA study of Depression and Anxiety that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 210 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06013137, a NA study of Depression and Anxiety, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
210 participants
Enrollment target
1
Study location

Study Summary

The research team would like to test how efficacious an artificial intelligence chatbot is in delivering supportive behavioral interventions in populations with anxiety, depression, or eating concerns.

Interventions

  • OTHER Therabot

Study Locations (1)

New Hampshire

  • Dartmouth College - Lebanon

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2024-03-11
Est. Completion 2024-08-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT06013137

The ClinicalTrials.gov registry entry for NCT06013137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Therabot is the first listed.

NCT06013137 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06013137 about?

NCT06013137 is a clinical study titled "Chatbot for Depression, Anxiety, and Eating Disorders". The research team would like to test how efficacious an artificial intelligence chatbot is in delivering supportive behavioral interventions in populations with anxiety, depression, or eating concerns.

What is the current status of trial NCT06013137?

This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2024-03-11. Estimated completion is 2024-08-30.

What conditions does trial NCT06013137 study?

This clinical trial studies the following conditions: Depression, Anxiety, Eating Disorders.

What interventions are being tested in trial NCT06013137?

The interventions under investigation include: Therabot (OTHER).

Who is sponsoring clinical trial NCT06013137?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06013137 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.